Jiapu Le (佳普乐)佳普乐
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 山东信谊制药有限公司Chinese legal name: 山东信谊制药有限公司
主要成分Active Ingredients
- 劳拉西泮Laola Xipan
药物知识说明
劳拉西泮是一种在国家药监局注册认定的药品。标注生产企业为山东信谊制药有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：山东信谊制药有限公司Chinese legal name: 山东信谊制药有限公司、山东信谊制药有限公司Chinese legal name: 山东信谊制药有限公司、山东信谊制药有限公司Chinese legal name: 山东信谊制药有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 佳普乐) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 山东信谊制药有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 山东信谊制药有限公司Chinese legal name: 山东信谊制药有限公司, 山东信谊制药有限公司Chinese legal name: 山东信谊制药有限公司, 山东信谊制药有限公司Chinese legal name: 山东信谊制药有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 佳普乐Recorded Chinese name: 佳普乐
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 1mg1 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 山东信谊制药有限公司Chinese legal name: 山东信谊制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20060105
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20060105
Manufacturer
Chinese legal name: 山东信谊制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20060105
生产企业
山东信谊制药有限公司(国产)
适应症
适用于焦虑障碍的治疗或用于缓解焦虑症状以及与抑郁症状相关的焦虑的短期治疗。与日常生活压力相关的焦虑或紧张，通常不需要抗焦虑药的治疗。 劳拉西泮长期应用的效果即应用4个月以上的效果还未经系统的临床研究评估。医师应定期重新评估该药对个体患者的有效性。
用法用量
成人每次1-2mg，每天2-3次。年老或体弱者减少用量。
不良反应
镇静、眩晕、虚弱、步态不稳，少见定向障碍、抑郁、胃肠道症状、头痛、睡眠紊乱、激越、皮肤症状、眼功能紊乱。
禁忌
对本品及苯二氮卓类药物过敏者、急性闭角型青光眼患者禁用。
注意事项
本品按二类精神药品管理。严重呼吸功能不全患者慎用。服用本品者不能驾车或操作机械。
贮藏
25℃以下避光保存。
规格
1mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.